We publish EVERYTHING sent to

Expert’s Opinion: Packaging Injectable Drug Products, Celltrion, Lonza Sign Drug Substance Mfg. Contract, and More in Today’s CP Direct!


Expert’s Opinion: Packaging Injectable Drug Products, Celltrion, Lonza Sign Drug Substance Mfg. Contract, and More in Today’s CP Direct!
 Trouble viewing this email? Read it online
Follow us on:       
Sponsored by Mettler Toledo
September 4, 2019
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Jones Packaging


Expert’s Opinion: Four Pitfalls to Avoid When Packaging Injectable Drug Products
Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities

Celltrion, Lonza Sign Contract to Manufacture Remsima Drug Substance
Lonza’s biologics facility in Singapore to cover EU and U.S. market needs

VALSYNTHESE – 125 Year Anniversary of the SSE Group
At Valsynthese we offer the full range of services to make chemical dreams from gram to ton-scale come true: Sourcing, samples, chemical development, analytical development and support, pilot production, commercial production and registration.
Learn More >>


Bora Secures FDA Approval for CDMO Services
Reports successful inspection of Zhunan, Taiwan site

Celyad Successfully Produces CYAD-01 with OptimAb Mfg. Process
Doses first patient in Phase I trial with CYAD-01, an investigational CAR-T therapy being evaluated in AML

Applying Chemistry and Engineering Expertise to Continuous Processing
Flow chemistry for the continuous production of small molecule active pharmaceutical ingredients (APIs) can provide significant safety, environmental, cost and quality benefits. Effective development and implementation of continuous manufacturing solutions requires a combination of chemistry and engineering expertise and the knowledge and experience to determine which processes are suitable for conversion from batch to continuous operations.
Learn More >>

Rentschler Biopharma Takes on New Projects at Milford, MA Facility
The site will support both clinical and commercial manufacturing programs

BiomX Completes In-house Phage Manufacturing Facility
Located in Ness Ziona, Israel new facility to support clinical manufacturing

Clinical and Regulatory Challenges for Cell and Gene Therapies
Cell and gene therapies have the potential to slow disease progression, improve outcomes, and in some cases, potentially cure illnesses. However, navigating through their complex clinical and regulatory hurdles can be challenging.
Learn key questions that pharma should consider during development >>

CROMSOURCE Expands Footprint in RTP NC
New location complements the company’s two existing U.S. offices and supports recent growth

July/August 2019

Latest Issue Check out the feature
from the latest issue.




Cost-Effective Solution to Filing Your CMC Supplement
Opioid Reformulation for Abuse Deterrence — Filed as a CMC Supplement in Less Than a Year

Microsite Spotlight

Emergent BioSolutions, Inc.
Emergent provides contract development and manufacturing services for bulk drug substances and parenteral drug products.
Literature / Brochures

We hope you enjoyed this edition of Contract Pharma Direct’s Newsletter

You are receiving this message because you opted in at To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address ( to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Montvale, NJ 07645 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2019 Contract Pharma All rights reserved.


Like!! Thank you for publishing this awesome article.

Leave a Reply